Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 8 studies | 23% ± 6% | |
plasmacytoid dendritic cell | 8 studies | 22% ± 6% | |
epithelial cell | 7 studies | 29% ± 11% | |
glutamatergic neuron | 6 studies | 39% ± 21% | |
ciliated cell | 5 studies | 29% ± 7% | |
non-classical monocyte | 5 studies | 26% ± 13% | |
macrophage | 5 studies | 23% ± 7% | |
astrocyte | 5 studies | 26% ± 13% | |
classical monocyte | 4 studies | 25% ± 7% | |
neuron | 4 studies | 21% ± 4% | |
type I pneumocyte | 4 studies | 18% ± 4% | |
GABAergic neuron | 4 studies | 36% ± 16% | |
oligodendrocyte | 4 studies | 22% ± 8% | |
goblet cell | 4 studies | 17% ± 2% | |
B cell | 3 studies | 19% ± 1% | |
myeloid cell | 3 studies | 23% ± 3% | |
fibroblast | 3 studies | 17% ± 1% | |
type II pneumocyte | 3 studies | 26% ± 5% | |
microglial cell | 3 studies | 24% ± 8% | |
oligodendrocyte precursor cell | 3 studies | 28% ± 9% | |
dendritic cell | 3 studies | 35% ± 17% | |
basal cell | 3 studies | 23% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2570.46 | 1445 / 1445 | 100% | 10.86 | 183 / 183 |
intestine | 100% | 2972.79 | 966 / 966 | 100% | 11.45 | 526 / 527 |
brain | 100% | 3829.23 | 2637 / 2642 | 100% | 11.95 | 704 / 705 |
lung | 100% | 2802.12 | 578 / 578 | 100% | 9.32 | 1151 / 1155 |
stomach | 100% | 2317.85 | 359 / 359 | 100% | 11.78 | 285 / 286 |
skin | 100% | 2695.19 | 1809 / 1809 | 100% | 9.90 | 470 / 472 |
breast | 100% | 2213.55 | 459 / 459 | 99% | 14.57 | 1112 / 1118 |
prostate | 100% | 2437.71 | 245 / 245 | 99% | 12.21 | 498 / 502 |
kidney | 100% | 2456.88 | 89 / 89 | 99% | 10.61 | 891 / 901 |
thymus | 100% | 2676.35 | 653 / 653 | 99% | 11.25 | 596 / 605 |
ovary | 100% | 2432.92 | 180 / 180 | 98% | 6.99 | 423 / 430 |
adrenal gland | 100% | 2858.58 | 258 / 258 | 98% | 9.73 | 226 / 230 |
pancreas | 100% | 1955.68 | 328 / 328 | 98% | 8.32 | 174 / 178 |
uterus | 100% | 2689.22 | 170 / 170 | 97% | 8.15 | 446 / 459 |
bladder | 100% | 2440.10 | 21 / 21 | 97% | 7.75 | 488 / 504 |
liver | 100% | 1539.49 | 226 / 226 | 90% | 5.73 | 366 / 406 |
adipose | 100% | 2139.29 | 1204 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 2309.84 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2999.15 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.74 | 1 / 1 |
blood vessel | 100% | 2311.53 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 1707.65 | 840 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 7.60 | 28 / 29 |
eye | 0% | 0 | 0 / 0 | 96% | 7.53 | 77 / 80 |
tonsil | 0% | 0 | 0 / 0 | 96% | 8.98 | 43 / 45 |
peripheral blood | 85% | 1425.23 | 790 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0097191 | Biological process | extrinsic apoptotic signaling pathway |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_2000352 | Biological process | negative regulation of endothelial cell apoptotic process |
GO_0006469 | Biological process | negative regulation of protein kinase activity |
GO_0032148 | Biological process | activation of protein kinase B activity |
GO_0032869 | Biological process | cellular response to insulin stimulus |
GO_0030512 | Biological process | negative regulation of transforming growth factor beta receptor signaling pathway |
GO_0019722 | Biological process | calcium-mediated signaling |
GO_0043536 | Biological process | positive regulation of blood vessel endothelial cell migration |
GO_0045766 | Biological process | positive regulation of angiogenesis |
GO_0071364 | Biological process | cellular response to epidermal growth factor stimulus |
GO_0048009 | Biological process | insulin-like growth factor receptor signaling pathway |
GO_0031295 | Biological process | T cell costimulation |
GO_0043304 | Biological process | regulation of mast cell degranulation |
GO_0018107 | Biological process | peptidyl-threonine phosphorylation |
GO_1905564 | Biological process | positive regulation of vascular endothelial cell proliferation |
GO_1903672 | Biological process | positive regulation of sprouting angiogenesis |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_0006972 | Biological process | hyperosmotic response |
GO_1903078 | Biological process | positive regulation of protein localization to plasma membrane |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0008286 | Biological process | insulin receptor signaling pathway |
GO_0003323 | Biological process | type B pancreatic cell development |
GO_0034122 | Biological process | negative regulation of toll-like receptor signaling pathway |
GO_0007173 | Biological process | epidermal growth factor receptor signaling pathway |
GO_0051281 | Biological process | positive regulation of release of sequestered calcium ion into cytosol |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0010518 | Biological process | positive regulation of phospholipase activity |
GO_0010667 | Biological process | negative regulation of cardiac muscle cell apoptotic process |
GO_0006468 | Biological process | protein phosphorylation |
GO_0043122 | Biological process | regulation of canonical NF-kappaB signal transduction |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0016477 | Biological process | cell migration |
GO_0005886 | Cellular component | plasma membrane |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0005925 | Cellular component | focal adhesion |
GO_0005829 | Cellular component | cytosol |
GO_0014069 | Cellular component | postsynaptic density |
GO_0005737 | Cellular component | cytoplasm |
GO_0042995 | Cellular component | cell projection |
GO_0005634 | Cellular component | nucleus |
GO_0016004 | Molecular function | phospholipase activator activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0043274 | Molecular function | phospholipase binding |
GO_0005524 | Molecular function | ATP binding |
GO_0004676 | Molecular function | 3-phosphoinositide-dependent protein kinase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PDPK1 |
Protein name | 3-phosphoinositide-dependent protein kinase 1 (hPDK1) (EC 2.7.11.1) non-specific serine/threonine protein kinase (EC 2.7.11.1) 3-phosphoinositide dependent protein kinase 1 3-phosphoinositide-dependent protein kinase 1 (EC 2.7.11.1) |
Synonyms | PDK1 |
Description | FUNCTION: Serine/threonine kinase which acts as a master kinase, phosphorylating and activating a subgroup of the AGC family of protein kinases. Its targets include: protein kinase B (PKB/AKT1, PKB/AKT2, PKB/AKT3), p70 ribosomal protein S6 kinase (RPS6KB1), p90 ribosomal protein S6 kinase (RPS6KA1, RPS6KA2 and RPS6KA3), cyclic AMP-dependent protein kinase (PRKACA), protein kinase C (PRKCD and PRKCZ), serum and glucocorticoid-inducible kinase (SGK1, SGK2 and SGK3), p21-activated kinase-1 (PAK1), protein kinase PKN (PKN1 and PKN2). Plays a central role in the transduction of signals from insulin by providing the activating phosphorylation to PKB/AKT1, thus propagating the signal to downstream targets controlling cell proliferation and survival, as well as glucose and amino acid uptake and storage. Negatively regulates the TGF-beta-induced signaling by: modulating the association of SMAD3 and SMAD7 with TGF-beta receptor, phosphorylating SMAD2, SMAD3, SMAD4 and SMAD7, preventing the nuclear translocation of SMAD3 and SMAD4 and the translocation of SMAD7 from the nucleus to the cytoplasm in response to TGF-beta. Activates PPARG transcriptional activity and promotes adipocyte differentiation. Activates the NF-kappa-B pathway via phosphorylation of IKKB. The tyrosine phosphorylated form is crucial for the regulation of focal adhesions by angiotensin II. Controls proliferation, survival, and growth of developing pancreatic cells. Participates in the regulation of Ca(2+) entry and Ca(2+)-activated K(+) channels of mast cells. Essential for the motility of vascular endothelial cells (ECs) and is involved in the regulation of their chemotaxis. Plays a critical role in cardiac homeostasis by serving as a dual effector for cell survival and beta-adrenergic response. Plays an important role during thymocyte development by regulating the expression of key nutrient receptors on the surface of pre-T cells and mediating Notch-induced cell growth and proliferative responses. Provides negative feedback inhibition to toll-like receptor-mediated NF-kappa-B activation in macrophages. Isoform 3 is catalytically inactive. . |
Accessions | H3BPR5 ENST00000441549.7 [O15530-5] H3BNV5 ENST00000566659.1 H3BQA3 ENST00000492021.6 E9PER6 ENST00000474706.6 ENST00000478708.2 H3BPW1 ENST00000268673.11 [O15530-4] ENST00000342085.9 [O15530-1] ENST00000389224.7 H3BQ10 ENST00000461815.1 O15530 |